Episode

172: Yes To Life Show with Robin Daly MBE - Episode 172

Podcast
UK Health Radio Podcast
Published
May 14, 2026
Duration seconds
2914
Processing state
not_requested
Canonical source
https://audioboom.com/posts/8900631
Audio
https://dts.podtrac.com/redirect.mp3/audioboom.com/posts/8900631.mp3?modified=1778168939&sid=5091717&source=rss
JSON
/v1/public/podcasts/uk-health-radio-podcast-5866409/episodes/172-yes-to-life-show-with-robin-daly-mbe-episode-172
Markdown
/podcast/uk-health-radio-podcast-5866409/172-yes-to-life-show-with-robin-daly-mbe-episode-172.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/uk-health-radio-podcast-5866409/episodes/172-yes-to-life-show-with-robin-daly-mbe-episode-172/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/uk-health-radio-podcast-5866409/172-yes-to-life-show-with-robin-daly-mbe-episode-172.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Episode 172 - Carpe Diem - Integrative Doctor Saskia Kloppenburg talks about the important issue of when to introduce integrative modalities into cancer care. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only. The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees. We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.